These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2495602)

  • 21. The role of RT1.a major histocompatibility antigens in prolonging the survival of hepatic allografts in the rat.
    Yamaguchi Y; Harland RC; Wyble C; Bollinger RR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):792-3. PubMed ID: 2650272
    [No Abstract]   [Full Text] [Related]  

  • 22. Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells.
    Jin MX; Chowdhury NC; James T; Engelstad K; Hardy MA; Oluwole SF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):291. PubMed ID: 8438304
    [No Abstract]   [Full Text] [Related]  

  • 23. Tolerance to cardiac allografts induced in utero with fetal liver cells.
    Yuh DD; Gandy KL; Hoyt G; Reitz BA; Robbins RC
    Circulation; 1996 Nov; 94(9 Suppl):II304-7. PubMed ID: 8901765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of FK 506 on graft survival in rat small intestinal allografts.
    Date K; Okajima K; Takeda Y; Isozaki H; Tezuka K; Ryo T
    Transplant Proc; 1992 Jun; 24(3):1173. PubMed ID: 1376516
    [No Abstract]   [Full Text] [Related]  

  • 25. Recipient blood pre-transplant transfusion prolongs hepatic allograft survival in rats.
    Wang FS; Yamaguchi Y; Furuhashi T; Uchino S; Kihara S; Yamada S; Mori K; Ogawa M
    J Surg Res; 2006 Sep; 135(1):52-60. PubMed ID: 16716354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolongation of cardiac allograft survival following intraportal injection of donor antigen is inhibited by cyclosporine A.
    Farges O; Buffello D; Shi YM; Moufetier A; Bismuth H
    Transplant Proc; 1995 Aug; 27(4):2525-7. PubMed ID: 7652915
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of perioperative portal venous administration of donor lymphocytes on survival of rat cardiac allografts and renal grafts of the mongrel dog.
    Hirakawa K; Yoshimura N; Lee CJ; Yasui H; Ohsaka Y; Hamashima T; Oka T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):346-7. PubMed ID: 8438328
    [No Abstract]   [Full Text] [Related]  

  • 28. Differential in vivo function of splenocytes and lymphocytes harvested from rejecting allografts.
    Heidecke CD; Brauer R; Schneider-Eicke J; Schatschneider S; Stadler J
    Transplant Proc; 1989 Feb; 21(1 Pt 1):184-5. PubMed ID: 2650103
    [No Abstract]   [Full Text] [Related]  

  • 29. Intrathymic injection of allogeneic cells induces indefinite survival of cardiac but not small bowel grafts.
    Xia W; Sayegh MH; Kirkman RL
    Transplant Proc; 1994 Jun; 26(3):1581. PubMed ID: 8030045
    [No Abstract]   [Full Text] [Related]  

  • 30. Prolongation of rat heart allografts by donor-specific blood transfusion treated with ultraviolet irradiation.
    Oluwole SF; Iga C; Lau H; Hardy MA
    J Heart Transplant; 1985; 4(4):385-9. PubMed ID: 2956395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment of recipients with mitomycin-C-treated spleen cells induces significant prolongation of cardiac allograft survival in rats.
    Tanigawa T; Monden M; Gotoh M; Nagano H; Hasuike Y; Fukuzaki T; Akagi K; Yoshida T; Ota H; Mori T
    Transplant Proc; 1994 Dec; 26(6):3359-60. PubMed ID: 7998173
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute rejection of small bowel allografts in rats: protection afforded by pyruvate.
    Cicalese L; Subbotin V; Rastellini C; Rao AS; Stanko RT
    Transplant Proc; 1996 Oct; 28(5):2474. PubMed ID: 8907909
    [No Abstract]   [Full Text] [Related]  

  • 33. Prolongation of small bowel allografts after intrathymic injection of donor alloantigen and ALS.
    Goss JA; Nakafusa Y; Flye MW
    J Surg Res; 1993 May; 54(5):494-8. PubMed ID: 8361174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506.
    Takara T; Tchervenkov JI; Guttman FM; Fecteau A; Rosenmann E
    Transplant Proc; 1994 Jun; 26(3):1622. PubMed ID: 7518150
    [No Abstract]   [Full Text] [Related]  

  • 35. Donor-specific transfusion using mitomycin-C treated spleen cells induces significant prolongation of cardiac allograft in rats.
    Tanigawa T; Gotoh M; Nagano H; Ota H; Hasuike Y; Yoshida T; Sakon M; Monden M
    Transplant Proc; 1997; 29(1-2):1149-50. PubMed ID: 9123243
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum suppressive factor appears to potentiate cardiac allograft survival after portal vein injection of ultraviolet B-irradiated donor spleen cells.
    Yu S; Nakafusa Y; Flye MW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):500-1. PubMed ID: 8438394
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of intrathymic injection of donor splenocytes on rat small bowel allograft survival.
    Karim MS; Webster GA; Wood RF; Pockley AG
    Transplant Proc; 1994 Jun; 26(3):1583-4. PubMed ID: 8030047
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of passenger leukocytes in the immunogenicity of intestinal and cardiac allografts in the rat.
    Gundlach M; Wasfie T; D'Agati V; Chabot J; Oluwole S; Hardy MA
    Transplant Proc; 1991 Feb; 23(1 Pt 1):187-8. PubMed ID: 1990510
    [No Abstract]   [Full Text] [Related]  

  • 39. Duration of donor-specific tolerance after intrathymic administration of alloantigen.
    Arima T; Nakafusa Y; Goss JA; Walp LA; Yu S; Flye MW
    Transplant Proc; 1995 Feb; 27(1):136-7. PubMed ID: 7878912
    [No Abstract]   [Full Text] [Related]  

  • 40. Intraportal injection of specific allogeneic cells can prolong neonatal intestinal free graft survival.
    Lee SK; Perez-Atayde A; Takeda T; Vacanti JP; Lund DP
    Transplant Proc; 1994 Jun; 26(3):1579-80. PubMed ID: 8030044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.